XML 36 R15.htm IDEA: XBRL DOCUMENT
v3.20.4

Accrued Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2020
Payables And Accruals [Abstract] |
Accrued Liabilities | Note 8 – Accrued Liabilities Amounts reported in ‘Accrued liabilities’ in the balance sheets were (in thousands):
|  | December 31, |
|  | 2020 |  |  | 2019 |
Compensation related accruals |  | $ | 3,975 |  |  | $ | 1,165 |
Accrued clinical trial expense |  |  | 715 |  |  |  | 620 |
Other expenses |  |  | 3,099 |  |  |  | 2,352 |
Warrant liability, current |  | - |  |  |  | 43 |
Total accrued liabilities |  | $ | 7,789 |  |  | $ | 4,180 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration